Alzinova AB (ALZ) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.039x

Based on the latest financial reports, Alzinova AB (ALZ) has a cash flow conversion efficiency ratio of -0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-5.01 Million ≈ $-539.59K USD) by net assets (Skr127.85 Million ≈ $13.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Alzinova AB - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how Alzinova AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ALZ total liabilities for a breakdown of total debt and financial obligations.

Alzinova AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alzinova AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Jain Irrigation Systems Limited
NSE:JISLDVREQS
0.020x
GreenPower Motor Company Inc
NASDAQ:GP
-0.021x
Indo Komoditi Korpora Tbk PT
JK:INCF
0.024x
Olympio Metals Ltd
AU:OLY
-2.352x
CPPGroup Plc
F:4CV1
-2.851x
Corus Entertainment Inc
TO:CJR-B
0.077x
OLB Group Inc
NASDAQ:OLB
-0.022x
Funding Circle Holdings PLC
LSE:FCH
0.003x

Annual Cash Flow Conversion Efficiency for Alzinova AB (2014–2024)

The table below shows the annual cash flow conversion efficiency of Alzinova AB from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Alzinova AB stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr123.82 Million
≈ $13.33 Million
Skr-20.27 Million
≈ $-2.18 Million
-0.164x -22.49%
2023-12-31 Skr113.86 Million
≈ $12.25 Million
Skr-15.21 Million
≈ $-1.64 Million
-0.134x -36.72%
2022-12-31 Skr105.53 Million
≈ $11.36 Million
Skr-10.31 Million
≈ $-1.11 Million
-0.098x +11.95%
2021-12-31 Skr88.47 Million
≈ $9.52 Million
Skr-9.82 Million
≈ $-1.06 Million
-0.111x -70.10%
2020-12-31 Skr96.02 Million
≈ $10.33 Million
Skr-6.27 Million
≈ $-674.29K
-0.065x +2.98%
2019-12-31 Skr59.11 Million
≈ $6.36 Million
Skr-3.98 Million
≈ $-427.85K
-0.067x -8.08%
2018-12-31 Skr63.75 Million
≈ $6.86 Million
Skr-3.97 Million
≈ $-426.95K
-0.062x +14.16%
2017-12-31 Skr29.39 Million
≈ $3.16 Million
Skr-2.13 Million
≈ $-229.31K
-0.072x +16.33%
2016-12-31 Skr31.90 Million
≈ $3.43 Million
Skr-2.76 Million
≈ $-297.46K
-0.087x +44.29%
2015-12-31 Skr20.63 Million
≈ $2.22 Million
Skr-3.21 Million
≈ $-345.40K
-0.156x +66.23%
2014-12-31 Skr1.55 Million
≈ $167.09K
Skr-715.19K
≈ $-76.97K
-0.461x --

About Alzinova AB

ST:ALZ Sweden Biotechnology
Market Cap
$4.97 Million
Skr46.16 Million SEK
Market Cap Rank
#28380 Global
#642 in Sweden
Share Price
Skr0.44
Change (1 day)
-1.67%
52-Week Range
Skr0.44 - Skr2.18
All Time High
Skr26.90
About

Alzinova AB (publ), a clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer's disease in Sweden. Its lead product candidate is the ALZ-101, a therapeutic vaccine for the treatment of Alzheimer's disease, which has completed phase 1b study. The company also develops ALZ-201, a monoclonal antibody that target and neutralize the neurotoxic forms of the peptide Aß42, call… Read more